Staccato® Loxapine Treatment of Agitation in Bipolar Disorder Patients

Update Il y a 4 ans
Reference: NCT00721955

Woman and Man

Extract

Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in bipolar 1 disorder patients.


Inclusion criteria

  • Bipolar I Disorder

Links